Critical Parameters to Improve Pancreatic Cancer Treatment Using Magnetic Hyperthermia: Field Conditions, Immune Response, and Particle Biodistribution
Open Access
- 12 March 2021
- journal article
- research article
- Published by American Chemical Society (ACS) in ACS Applied Materials & Interfaces
- Vol. 13 (11) , 12982-12996
Abstract
Magnetic hyperthermia (MH) was used to treat a murine model of pancreatic cancer. This type of cancer is generally characterized by the presence of dense stroma that acts as a barrier for chemotherapeutic treatments. Several alternating magnetic field (AMF) conditions were evaluated using three-dimensional (3D) cell culture models loaded with magnetic nanoparticles (MNPs) to determine which conditions were producing a strong effect on the cell viability. Once the optimal AMF conditions were selected, in vivo experiments were carried out using similar frequency and field amplitude parameters. A marker of the immune response activation, calreticulin (CALR), was evaluated in cells from a xenograft tumor model after the MH treatment. Moreover, the distribution of nanoparticles within the tumor tissue was assessed by histological analysis of tumor sections, observing that the exposure to the alternating magnetic field resulted in the migration of particles toward the inner parts of the tumor. Finally, a relationship between an inadequate body biodistribution of the particles after their intratumoral injection and a significant decrease in the effectiveness of the MH treatment was found. Animals in which most of the particles remained in the tumor area after injection showed higher reductions in the tumor volume growth in comparison with those animals in which part of the particles were found also in the liver and spleen. Therefore, our results point out several factors that should be considered to improve the treatment effectiveness of pancreatic cancer by magnetic hyperthermia.Keywords
Funding Information
- Universidad de Zaragoza (Beca Santander-UNIZAR L.B., Beca Santander-UNIZAR Y.F.A., JIUZ-2018-CIE-03, UZ-2018-CIE-03)
- Ministerio de Ciencia, Innovaci?n y Universidades (BIO2017-84246-C2-1-R, PGC2018-096016-B-I00)
- European Commission (DT-NMBP-02-2018, ID: 814439)
- Ministerio de Econom?a y Competitividad (PCIN-2017-060, RYC-2014-15512, RYC-2015-17640)
This publication has 70 references indexed in Scilit:
- Causes, consequences, and remedies for growth-induced solid stress in murine and human tumorsProceedings of the National Academy of Sciences, 2012
- Ferroptosis: An Iron-Dependent Form of Nonapoptotic Cell DeathCell, 2012
- Magnetic nanoparticle biodistribution following intratumoral administrationNanotechnology, 2011
- Nanoparticle distribution and temperature elevations in prostatic tumours in mice during magnetic nanoparticle hyperthermiaInternational Journal of Hyperthermia, 2011
- Ac magnetic susceptibility study of in vivo nanoparticle biodistributionJournal of Physics D: Applied Physics, 2011
- Efficacy and safety of intratumoral thermotherapy using magnetic iron-oxide nanoparticles combined with external beam radiotherapy on patients with recurrent glioblastoma multiformeJournal of Neuro-Oncology, 2010
- Engineering biofunctional magnetic nanoparticles for biotechnological applicationsNanoscale, 2010
- Magnetic nanoparticle hyperthermia for prostate cancerInternational Journal of Hyperthermia, 2010
- The role of dipolar interaction in the quantitative determination of particulate magnetic carriers in biological tissuesPhysics in Medicine & Biology, 2007
- Monodisperse MFe2O4 (M = Fe, Co, Mn) NanoparticlesJournal of the American Chemical Society, 2003